Elizabeth Bhatt, the President and COO of $SEPN, sold 4,000 shares of the company on 07-15-2026 for an estimated $135,974. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.2% of their shares of this class of stock. Following this trade, they now own 174,209 shares of this class of $SEPN stock.
$SEPN Insider Trading Activity
$SEPN insiders have traded $SEPN stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $SEPN stock by insiders over the last 6 months:
- SAMIRA SHAIKHLY (Chief People Officer) has made 0 purchases and 8 sales selling 96,614 shares for an estimated $2,802,023.
- DANIEL D. LONG (SVP, Drug Discovery) has made 0 purchases and 4 sales selling 18,333 shares for an estimated $647,109.
- ELIZABETH BHATT (President and COO) has made 0 purchases and 6 sales selling 12,000 shares for an estimated $349,177.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$SEPN Hedge Fund Activity
We have seen 56 institutional investors add shares of $SEPN stock to their portfolio, and 48 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRIMECAP MANAGEMENT CO/CA/ added 502,734 shares (+92.1%) to their portfolio in Q1 2026, for an estimated $12,080,698
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 413,898 shares (-8.6%) from their portfolio in Q1 2026, for an estimated $9,945,968
- WOODLINE PARTNERS LP removed 385,310 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $9,258,999
- BVF INC/IL removed 367,533 shares (-21.4%) from their portfolio in Q1 2026, for an estimated $8,831,817
- BALYASNY ASSET MANAGEMENT L.P. added 233,108 shares (+6527.8%) to their portfolio in Q1 2026, for an estimated $5,601,585
- GOLDMAN SACHS GROUP INC added 191,298 shares (+7.0%) to their portfolio in Q1 2026, for an estimated $4,596,890
- MARSHALL WACE, LLP removed 187,061 shares (-82.4%) from their portfolio in Q1 2026, for an estimated $4,495,075
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$SEPN Analyst Ratings
Wall Street analysts have issued reports on $SEPN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 01/20/2026
To track analyst ratings and price targets for $SEPN, check out Quiver Quantitative's $SEPN forecast page.
$SEPN Price Targets
Multiple analysts have issued price targets for $SEPN recently. We have seen 6 analysts offer price targets for $SEPN in the last 6 months, with a median target of $44.0.
Here are some recent targets:
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $40.0 on 07/01/2026
- Srikripa Devarakonda from Truist Securities set a target price of $43.0 on 07/01/2026
- Seamus Fernandez from Guggenheim set a target price of $45.0 on 07/01/2026
- Martin Auster from Raymond James set a target price of $53.0 on 06/08/2026
- Tessa Romero from JP Morgan set a target price of $38.0 on 03/24/2026
- Derek Archila from Wells Fargo set a target price of $48.0 on 03/03/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
